Skip to content

CareDx CDNA Common Stock Shares Issued

Common Stock Shares Issued at other companies

NeoGenomics logo
NeoGenomicsNEO
129.7M+1.0%
GeneDx Holdings logo
GeneDx HoldingsWGS
29.7M+4.0%
Veracyte logo
VeracyteVCYT
79.8M+1.9%
Natera, Inc. logo
Natera, Inc.NTRA
Guardant Health logo
Guardant HealthGH
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's common stock shares issued?
CareDx (CDNA) reported common stock shares issued of 51.3M in Q1 2026.
How has CareDx's common stock shares issued changed year-over-year?
CareDx's common stock shares issued decreased by 7.6% year-over-year, from 55.5M to 51.3M.
What is the long-term trend for CareDx's common stock shares issued?
Over 5 years (2020 to 2025), CareDx's common stock shares issued has grown at a 0.6% compound annual growth rate (CAGR), from 49.4M to 50.9M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.